COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,234 Articles (22,733 medRxiv, 8,501 bioRxiv)

Most recent first Previous |  Page 1506: Articles 15051-15060  | Next

DEFINE: A Phase IIa Randomised Controlled Trial to Evaluate Repurposed Treatments for COVID-19
Gaughan, E., Quinn, T. M., Bruce, A., Antonelli, J., Young, V., Mair, J., Akram, A., Hirani, N., Koch, O., Mackintosh, C., Norrie, J., Dear, J. W., Dhaliwal, K.
10.1101/2021.05.20.21257513 — Posted: 2021-05-23
Anti-Sars-Cov-2 IgA And IgG In Human Milk After Vaccination Is Dependent On Vaccine Type And Previous Sars-Cov-2 Exposure: A Longitudinal Study.
Selma-Royo, M., Bauerl, C., Mena-Tudela, D., Aguilar-Camprubi, L., Perez-Cano, F. J., Parra-Llorca, A., Lerin, C., Martinez-Costa, C., COLLADO, M. C.
10.1101/2021.05.20.21257512 — Posted: 2021-05-23 Discussion: Offsite
Modeling third waves of Covid-19 spread with piecewise differential and integral operators: Turkey, Spain and Czechia
Atangana, A., IGRET ARAZ, S.
10.1101/2021.05.20.21257515 — Posted: 2021-05-23
Rapid And high throughput RT-qPCR assay for identification and differentiation between SARS-CoV-2 variants B.1.1.7 and B.1.351
Erster, O., Mendelson, E., Levy, V., Kabat, A., Mannasse, B., Asraf, H., Azar, R., Ali, Y., Shirazi, R., Bucris, E., Bar-Ilan, D., Mor, O., Mandelboim, M., Sofer, D., Fleishon, S., Zukerman, N. S.
10.1101/2021.05.19.21257439 — Posted: 2021-05-22
Implementation of a qPCR assay coupled with genomic surveillance for real-time monitoring of SARS-CoV-2 variants of concern.
Rego, N., Costabile, A., Paz, M., Salazar, C., Perbolianachis, P., Spangemberg, L., Ferres, I., Arce, R., Fajardo, A., Arleo, M., Possi, T., Bellini, I., Bilbao, L., Reyes, N., Bentancor, M. N., Lizosain, A., Benitez, M. J., Castells, M., Victoria, M., Maya, L., Bortagaray, V., Moller, A., Bello, G., Arantes, I., Brandes, M., Smircich, P., Chappos, O., Duquia, M., Gonzalez, B., Griffero, L., Mendez, M., Techera, M. P., Zanetti, J., Rivera, B., Maidana, M., Alonso, M., Alonso, C., Medina, J., Albornoz, H., Colina, R., Noya, V., Iraola, G., Fernandez-Calero, T., Moratorio, G. A., Moreno, P.
10.1101/2021.05.20.21256969 — Posted: 2021-05-22
SARS-CoV-2 vaccination with CoronaVac: seroconversion rate in healthcare workers after 40 days
Bochnia-Bueno, L., De Almeida, S. M., Raboni, S. M., Adamoski, D., Amadeu, L. L. M., Carstensen, S., Nogueira, M. B.
10.1101/2021.05.20.21255825 — Posted: 2021-05-22
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-B.1.1.7 or B.1.1.7 SARS-CoV-2 variants.
Monel, B., Planas, D., Grzelak, L., Smith, N., Robillard, N., Staropoli, I., Goncalves, P., Porrot, F., Guivel-Benhassine, F., Demory, N., Rodary, J., Puech, J., Euzen, V., Belec, L., Orvoen, G., Nunes, L., Moulin, V., Fourgeaud, J., Wack, M., Imbeaud, S., Campagne, P., Duffy, D., Di Santo, J., Bruel, T., Pere, H., Veyer, D., Schwartz, O.
10.1101/2021.05.20.21257393 — Posted: 2021-05-22
COVID symptoms, testing, shielding impact on patient reported outcomes and early vaccine responses in individuals with multiple myeloma
Ramasamy, K., Sadler, R., Jeans, S., Varghese, S., Turner, A., Larham, J., Gray, N., Barrett, J., Bowcock, S., Cook, G., Kyriakou, C., Smith, D., Drayson, M., Basu, S., Moore, S., McDonald, S., Gooding, S., Javaid, M. K.
10.1101/2021.05.20.21257379 — Posted: 2021-05-22
Assessing the Impact of Human Mobility to Predict Regional Excess Death in Ecuador
Cuellar, L., Torres, I., Romero-Severson, E. O., Mahesh, R., Ortega, N., Pungitore, S., Ke, R., Hengartner, N.
10.1101/2021.05.19.21257056 — Posted: 2021-05-22
Reactogenicity of homologous and heterologous prime-boost immunization with BNT162b2 and ChAdOx1-nCoV19: a prospective cohort study
Hillus, D., Tober-Lau, P., Hastor, H., Helbig, E. T., Lippert, L. J., Thibeault, C., Solarek, A., Kalle, C. v., Corman, V. M., Kopankiewicz, P., Suttorp, N., Bias, H., Seybold, J., Kurth, F., Sander, L. E.
10.1101/2021.05.19.21257334 — Posted: 2021-05-22 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).